Trial · NCT07025330
Registered outcomes40
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 40
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in volume on FDG-PET/MRI of lacrimal gland(s) and/or | From Baseline to Week 12 | |
| Primary | Change in volume on FDG-PET/MRI of salivary gland(s) and/or | From Baseline to Week 12 | Salivary glands include parotid glands, submandibular glands, sublingual glands |
| Primary | Change in volume of pancreas on FDG-PET/MRI | From Baseline to Week 12 | |
| Secondary | Change in FDG avidity (SUVmax) of lacrimal glands on PET | Baseline to Week 12 | |
| Secondary | Change in FDG avidity (SUVmean) of lacrimal glands on PET | Baseline to Week 12 | |
| Secondary | Change in FDG avidity (total gland glycolysis) of lacrimal glands on PET | Baseline to Week 12 | Total gland glycolysis is SUVmean x gland volume |
| Secondary | Change in FDG avidity (SUVmax) of salivary glands on PET | Baseline to Week 12 | |
| Secondary | Change in FDG avidity (SUVmean) of salivary glands on PET | Baseline to Week 12 | |
| Secondary | Change in FDG avidity (total gland glycolysis) of salivary glands on PET | Baseline to Week 12 | Total gland glycolysis is SUVmean x gland volume |
| Secondary | Change in FDG avidity (SUVmax) of pancreas on PET | Baseline to Week 12 | |
| Secondary | Change in FDG avidity (SUVmean) of pancreas on PET | Baseline to Week 12 | |
| Secondary | Change in FDG avidity (total pancreatic glycolysis) of pancreas on PET | Baseline to Week 12 | Total pancreatic glycolysis is SUVmean x pancreatic volume |
| Secondary | Change in exchange transfer (K^trans) of lacrimal glands on MRI | From Baseline to Week 12 | |
| Secondary | Change in apparent diffusion coefficient (ADC) of lacrimal glands on MRI | From Baseline to Week 12 | |
| Secondary | Change in microvascular volume fraction (f) of lacrimal glands on MRI | From Baseline to Week 12 | |
| Secondary | Change in exchange transfer (K^trans) of salivary glands on MRI | From Baseline to Week 12 | |
| Secondary | Change in apparent diffusion coefficient (ADC) of salivary glands on MRI | From Baseline to Week 12 | |
| Secondary | Change in microvascular volume fraction (f) of salivary glands on MRI | From Baseline to Week 12 | |
| Secondary | Change in apparent diffusion coefficient (ADC) of pancreas on MRI | From Baseline to Week 12 | |
| Secondary | Change in T1 mapping of pancreas on MRI | From Baseline to Week 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07025330/registered